Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
21 March 2024
|
|
N 16:55 | Norelgestromin 6 changes history +40,579 [Alara E. Dagsali (6×)] | |||
|
|
16:55 (cur | prev) +43 Alara E. Dagsali talk contribs | ||||
|
|
16:53 (cur | prev) +12,388 Alara E. Dagsali talk contribs | ||||
|
|
16:28 (cur | prev) +22,456 Alara E. Dagsali talk contribs | ||||
|
|
08:46 (cur | prev) +1,580 Alara E. Dagsali talk contribs | ||||
|
|
08:35 (cur | prev) +929 Alara E. Dagsali talk contribs | ||||
| N |
|
08:33 (cur | prev) +3,183 Alara E. Dagsali talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |OTC=Yes |genericName=NORELGESTROMIN AND ETHINLY ESTRADIOL patch |indicationType=prevention |indication=Norelgestromin and ethinyl estradiol transdermal system is indicated for the prevention of pregnancy in women with a body mass index (BMI) < 30 kg/m for whom a combined hormonal contraceptive is appropriate. |hasBlackBoxWarning=Yes |adverseReactions=The following serious adverse reactions with the use of co...") | |||